Apollo endosurgery announces inducement grant

Austin, tx / accesswire / march 19, 2021 / apollo endosurgery, inc. ("apollo") (nasdaq:apen), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to chas mckhann in connection with his appointment as the company's ceo in march 2021. the company's board of directors granted chas a stock option to purchase an aggregate of 848,733 shares of common stock, at a per share exercise price of $5.95, and a performance-based restricted stock unit award for 707,278 shares of common stock.
APEN Ratings Summary
APEN Quant Ranking